Related Articles
ABT‑737 increases cisplatin sensitivity through the ROS‑ASK1‑JNK MAPK signaling axis in human ovarian cancer cisplatin‑resistant A2780/DDP cells
Effects of ABT‑737 combined with irradiation treatment on uterine cervical cancer cells
A‑1210477, a selective MCL‑1 inhibitor, overcomes ABT‑737 resistance in AML
Combined treatment with ABT-737 and VX-680 induces apoptosis in Bcl-2- and c-FLIP-overexpressing breast carcinoma cells
ABT-737 potentiates cisplatin-induced apoptosis in human osteosarcoma cells via the mitochondrial apoptotic pathway